In vitro production of interleukin 1 by normal and malignant human B lymphocytes.
Open Access
- 1 March 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 136 (5) , 1688-1692
- https://doi.org/10.4049/jimmunol.136.5.1688
Abstract
In this study, the capacity of normal and neoplastic B lymphocytes to release interleukin 1 (IL 1) has been investigated. Peripheral blood B cells from normal donors were isolated by depletion of E rosetting cells and by positive selection of cells expressing surface immunoglobulin (sIg) or the B1 marker. Peripheral blood B cells from patients with B cell chronic lymphocytic leukemia (B-CLL) were purified by removal of E rosetting cells followed by complement-mediated cytotoxicity with selected monoclonal antibodies. All of the normal B cell suspensions and the large majority of the B-CLL cells produced in culture high amounts of IL 1 in the absence of any apparent stimulus. Control experiments ruled out that small numbers of monocytes in the B cell suspensions could represent the source of IL 1. These data support the contention that B cells participate to the immune response as accessory cells for T cell activation not only by physically presenting antigen, but also by releasing IL 1.This publication has 3 references indexed in Scilit:
- Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation.The Journal of Immunology, 1984
- Analysis of HLA-DR polymorphism by two-dimensional peptide mapping.Proceedings of the National Academy of Sciences, 1981
- Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulinsJournal of Immunological Methods, 1977